Cytokine Release Syndrome
October 22, 2025
Introduction The approval and availability of cancer immunotherapies have significantly advanced treatment outcomes for patients with melanoma and with other…
The Immunotherapy 360 blog space features articles that encompass prominent issues related to immunotherapy. These are written with the assistance of the staff at AIM at Melanoma, AIM with Immunotherapy and health care practitioners.
If you have an idea for a future article, please reach out to us on our contact page!
Recent Posts
Oct. 22, 2025
Cytokine Release Syndrome
Oct. 09, 2025
Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation
Sep. 23, 2025